China Medical System Holdings Limited (CMS) repurchased 400,000 ordinary shares on 17 June 2026 through on-market transactions at prices ranging from HKD 10.20–10.32 per share, for a total consideration of HKD 4.11 million. The volume-weighted average price was approximately HKD 10.28.

Following the transaction, the company’s issued shares (excluding treasury shares) declined by 0.0164 % to 2.43 billion, while treasury shares rose to 5.90 million. The overall issued share count remains 2.44 billion.

The buy-back forms part of a mandate approved on 23 April 2026 that authorises the repurchase of up to 243.95 million shares. Including the latest purchase, CMS has repurchased 5.90 million shares under this mandate, representing 0.2417 % of the share base at the time of approval.

In accordance with Hong Kong listing rules, CMS is subject to a moratorium on issuing new shares or disposing of treasury shares until 17 July 2026.